書誌事項
- タイトル別名
-
- Monoclonal rheumatoid factor in a patient with multiple myeloma after chemotherapy.
この論文をさがす
抄録
A patient with multiple myeloma was treated with several cycles of chemotherapy and developed monoclonal IgA rheumatoid factor.<br> The monoclonal rheumatoid factor in this case reacted with 2 types of monoclonal antiidiotypic antibody derived from monoclonal rheumatoid factors in a patient with Sjögren's syndrome and a patient with macroglobulinemia.<br> Two possible mechanisms accounting for the developement of rheumatoid factor activity during a course of chemotherapy are discussed. The first possibility is that the rheumatoid factor or activity had been initially covered by an antiidiotypic antibody but was disclosed by the decreased production of this antibody following by the immunosuppressive therapy. The second possibility is that monoclonal IgA acquired rheumatoid factor activity by a point mutation resulting in a change in the molecular structure of the idiotype.
収録刊行物
-
- 日本臨床免疫学会会誌
-
日本臨床免疫学会会誌 19 (5), 519-523, 1996
日本臨床免疫学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204649767040
-
- NII論文ID
- 10016359141
-
- NII書誌ID
- AN00357971
-
- ISSN
- 13497413
- 09114300
-
- PubMed
- 8952321
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可